MedPath

Development of Quality of Life Tool for TBI

Completed
Conditions
Traumatic Brain Injury
Registration Number
NCT00714428
Lead Sponsor
US Department of Veterans Affairs
Brief Summary

Objectives: The ultimate goal of this research program is to promote seamless, comprehensive care for Operation Enduring Freedom/ Operation Iraqi Freedom (OEF/OIF) veterans. The purpose of this study is to develop a psychometrically sound tool to measure health-related quality of life (HRQOL) applicable to wounded warriors with TBI (deployment-related TBI).

Detailed Description

Specific short-term objectives for this study include:

O1: Identify a parsimonious set of domains that capture HRQOL in deployment-related TBI.

O2: Construct and refine clinically-relevant HRQOL of life item banks for deployment-related TBI, in order to supplement the TBI-QOL and generic Neuro-QOL banks and extend the TBI/Neuro-QOL projects to address the unique issues facing wounded warriors with TBI.

O3:Utilize Item Response Theory methodology to refine and calibrate targeted and generic item banks for use with deployment-related TBI.

O4:Develop a short form, refining item sets and developing algorithms for future development of a computerized adaptive test.

Research Design: The proposed three-year prospective study will employ a mixed methods research design in three stages. Combining qualitative and quantitative methods maximizes the ability of the study team to design and validate a clinically sensitive HRQOL measure for wounded warriors with deployment-related TBI. Furthermore, this approach is consistent with the FDA's draft guidance on patient reported outcome (PRO) measures development.

Phase 1: Qualitative data obtained from focus groups of veterans and VA providers will be used to (a) evaluate the generic Neuro-QOL domains and items for relevance and appropriateness for use in deployment-related TBI and (b) identify new HRQOL domains and items specific to deployment-related TBI. \[Objective #1\] Phase 2: The generic and specific item banks will be field tested in a large sample of veterans with deployment-related TBI recruited from all 4 VA Polytrauma Rehabilitation Centers (PRCs). \[Objective #2\] Phase 3: Psychometric analyses, including item response theory (IRT) of field test data will be completed. The psychometric properties of the scale will be evaluated empirically. A short form will be developed, refining item sets and developing algorithms for future development of a computerized adaptive test (CAT). \[Objectives #3 \& 4\]

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
485
Inclusion Criteria
  • enrolled in VA and diagnosed with a deployment-related TBI documented in computerized patient record system (CPRS)
  • at least one year post injury
  • greater than 18 years of age
  • able to follow two step commands and
  • English speaking

Clinicians Inclusion Criteria:

  • Clinicians, including:

    • physicians
    • psychologists
    • nurses
    • social workers
    • therapists who have provided care to wounded warriors with deployment-related TBI for at least three years
Exclusion Criteria

Veterans Exclusion criteria include:

  • those veterans who are not yet discharged from initial rehabilitation (want patients to experience community based living environment)
  • living in the community less than three months post initial rehabilitation, including residential care or long term care living environments

No exclusion criteria for the clinicians

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
development of an outcomes measureone time
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

VA Palo Alto Health Care System

🇺🇸

Palo Alto, California, United States

James A. Haley Veterans' Hospital

🇺🇸

Tampa, Florida, United States

VA Medical Center, Minneapolis

🇺🇸

Minneapolis, Minnesota, United States

Hunter Holmes McGuire VA Medical Center

🇺🇸

Richmond, Virginia, United States

VA Palo Alto Health Care System
🇺🇸Palo Alto, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.